Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Lung neoplasm malignant: Which Medications Are Safest? (632 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

632 medications are used for Lung neoplasm malignant, with 47,113 combined adverse event reports. The most reported drugs for Lung neoplasm malignant are ERLOTINIB and OSIMERTINIB.

47,113
Total Reports
632
Drugs Used

All Medications for Lung neoplasm malignant Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
ERLOTINIB Erlotinib 9,207 6,791 3,693 30.2%
OSIMERTINIB TAGRISSO 4,754 12,456 5,277 44.9%
NIVOLUMAB OPDIVO 4,197 23,086 36,530 26.3%
PEMBROLIZUMAB KEYTRUDA 3,575 15,543 35,472 18.6%
CARBOPLATIN Carboplatin 3,487 12,544 35,869 14.9%
ALECTINIB ALECENSA 2,932 1,055 1,553 11.5%
PEMETREXED Pemetrexed 2,422 3,876 10,697 16.5%
CRIZOTINIB Xalkori 1,949 3,173 2,520 31.9%
BEVACIZUMAB JOBEVNE 1,810 17,498 23,114 22.4%
PACLITAXEL PACLITAXEL PACLITAXEL 1,747 12,030 31,638 15.6%
ATEZOLIZUMAB Tecentriq Hybreza 1,262 8,520 15,094 25.3%
TISLELIZUMAB TEVIMBRA 1,119 114 2,586 2.3%
CISPLATIN CISplatin 988 8,387 17,469 17.7%
BRIGATINIB Alunbrig 946 729 912 22.2%
ETOPOSIDE Avopef 858 11,780 17,699 22.4%
AFATINIB Gilotrif 824 1,346 2,055 22.1%
LORLATINIB Lorbrena 810 1,542 1,232 28.0%
GEFITINIB Gefitinib 779 1,047 853 22.3%
DURVALUMAB IMFINZI 641 5,088 5,968 29.7%
DABRAFENIB Tafinlar 610 4,165 5,325 21.6%

View all 632 drugs →

Most Reported Drugs for Lung neoplasm malignant

#1 most reported
#2 most reported
#3 most reported